Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERCC1-guided chemotherapy trial in advanced non-small cell lung cancer
ISRCTN02370070Phase 3Completed
- Sponsor
- University College London
- Start
- Oct 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial in non-small cell lung cancer (NSCLC) comparing cisplatin + pemetrexed with paclitaxel + pemetrexed (2 arms). Primary endpoints: Overall survival in ERCC1-positive patients and Overall survival in ERCC1-negative patients. Started Oct 2009; status: completed.
02
Drugs
cisplatinpemetrexedpaclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ISRCTN02370070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN02370070.